Aemetis, Inc. (AMTX) is entering a high-growth phase with its dairy RNG platform, supported by regulatory approvals, capacity expansion, and favorable policy developments. Eleven digesters produced 106,400 MMBtu of RNG in Q2, generating $3.1M in revenue. Capacity is expected to reach 550,000 MMBtus by year end and 1.0M MMBtus by the end of 2026. The company is also advancing a $30M MVR project at its California Ethanol plant and targeting an early 2026 IPO in India.
Aemetis, Inc. (AMTX) is experiencing significant growth in its Dairy Renewable Natural Gas (RNG) platform, driven by regulatory approvals, capacity expansion, and favorable policy developments. According to an updated coverage report from Stonegate Capital Partners [1], the company's 11 digesters produced 106,400 MMBtu of RNG in the second quarter of 2025, generating $3.1 million in revenue.
In June, the California Air Resources Board (CARB) approved seven new Low Carbon Fuel Standard (LCFS) pathways with a blended Carbon Intensity (CI) score of -384. This approval has substantially increased the LCFS credit value by approximately 120% [1]. The negative CI score indicates carbon-negative fuel production, removing more greenhouse gases than created during production and use.
The company's capacity expansion roadmap is equally impressive. Current production is expected to reach 550,000 MMBtus by year-end 2025, nearly a 5x increase from Q2 levels. Further expansion to 1.0 million MMBtu by the end of 2026 represents a 9x increase from current quarterly production rates [1]. This expansion coincides with $83 million in Section 48 investment tax credit sales and USDA-guaranteed 20-year financing, providing capital for continued expansion [1].
Aemetis is also advancing a $30 million Mechanical Vapor Recompression (MVR) project at its California ethanol plant. This project is projected to reduce natural gas usage by 80% and add $32 million in annual cash flow starting in 2026 [1]. Additionally, the company's India subsidiary is targeting an early 2026 Initial Public Offering (IPO) [1].
The company's RNG business shows significant growth potential with new CARB approvals substantially increasing credit values and production capacity set to expand 9x by 2026 [1]. The approvals unlock multiple monetization channels, including the sale of RNG molecules, D3 RIN credits, LCFS credits, and Section 45Z production tax credits [1].
References:
[1] Stonegate Capital Partners updates coverage on Aemetis, Inc. (NASDAQ: AMTX). (2025, August 14). Newsfile Corp. Retrieved from https://www.stocktitan.net/news/AMTX/stonegate-capital-partners-updates-coverage-on-aemetis-inc-amtx-q2-94cvpn1vfnsb.html
Comments

No comments yet